¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"individual normal occlusion"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • buccal occlusion
    º¼Âʸ¹°¸², ÇùÃø±³ÇÕ
  • edge-to-edge occlusion
    ³¡³¡¸Â¹°¸², ´Ü´Ü±³ÇÕ
  • eccentric occlusion
    Æí½É±³ÇÕ
  • end-to-end occlusion
    ³¡³¡¸Â¹°¸², ´Ü´Ü±³ÇÕ
  • false occlusion
    °ÅÁþ¸Â¹°¸², ºÎÁ¤±³ÇÕ
  • hyperfunctional occlusion
    ±â´ÉÇ×Áø¸Â¹°¸²
  • inverse occlusion
    ¹Ý´ë°¡¸²
  • impending occlusion
    Àý¹ÚÆó¼â
  • lateral occlusion
    °¡Âʸ¹°¸², Ãø¹æ±³ÇÕ
  • neutral occlusion
    Á¤»ó¸Â¹°¸², Á¤»ó±³ÇÕ
  • occlusion
    1. ¸·Èû, Æó»ö, Æó¼â 2. ¸Â¹°¸², ±³ÇÕ 3. °¡¸²
  • occlusion amblyopia
    °¡¸²¿øÀξà½Ã
  • occlusion rim
    ±³ÇÕÅ×
  • posterior occlusion
    ¾Æ·¡Åεڸ¹°¸², ¿ø½É±³ÇÕ
  • punctal occlusion
    ´«¹°Á¡Æó¼â, ´©Á¡Æó¼â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • normal distribution
    Á¤±ÔºÐÆ÷
  • normal dwarf
    Á¤»ó³­ÀåÀÌ
  • normal flora
    Á¤»ó±Õ¹«¸®
  • normal intestinal flora
    âÀÚÁ¤»ó±Õ¹«¸®
  • normal tension glaucoma
    Á¤»ó¾È¾Ð³ì³»Àå
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • normal pressure hydrocephalus
    Á¤»ó¾Ð¹°³úÁõ, Á¤»ó¾Ð¼öµÎÁõ
  • normal limit
    Á¤»óÇѰè
  • normal
    Á¤»ó-, ³ë¸£¸»
  • normal opsonin
    Á¤»ó¿É¼Ò´Ñ
  • normal pressure
    Á¤»ó¾Ð, Ç¥ÁؾÐ
  • normal state
    Á¤»ó»óÅÂ
  • normal value
    Á¤»óÄ¡
  • normal oxidizing solution
    ±ÔÁ¤»êÈ­¾×
  • normal saline solution
    (¢¡physiological salt) »ý¸®½Ä¿°¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • individual tray
    °¢°³(ÊÀËÁ)Æ®·¹ÀÌ.
  • individual variation
    °³Ã¼º¯ÀÌ.
  • abnormal bite =occlusion
    ÀÌ»ó±³ÇÕ
  • abocclusion =abnormal occlusion
    °³±³(ËÒÎá).
  • anterior choroidal artery occlusion syndrome
    Àü¸Æ¶ôÃѵ¿¸Æ Æó¼âÁõÈıº.
  • anterior occlusion
    ÀüÃø±³ÇÕ(ÀüÃø±³ÇÕ).
  • arterial occlusion
    µ¿¸ÆÆó¼â.
  • habitual occlusion
    ½À°ü¼º ±³ÇÕ(¡­Îáùê).
  • hemiretinal vein occlusion
    Àý¹Ý¸Á¸·Á¤¸ÆÆó¼â(Áõ)
  • hyperfunctional occlusion
    °úµµ±³ÇÕ(°úʱ³ÇÕ).
  • hyperfunctional occlusion
    °úµµ±³ÇÕ(ΦöôÎá ùê).
  • ideal occlusion
    ÀÌ»ó±³ÇÕ(ìµßÌÎáùê).
  • impending occlusion
    Àý¹ÚÆó¼â
  • posterior occlusion
    ÈÄÃø±³ÇÕ(ÈÄÃø±³ÇÕ).
  • progenia =opposite occlusion
    ÇϾÇÀüµ¹(Áõ)(ù»äÉîñÔÍñø), ¹Ý´ë±³ÇÕ(ÚãÓß Îáùê).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • common opsonin =normal o.
    Á¤»ó(ïáßÈ)¿É¼Ò´Ñ.
  • flora, normal
    Á¤»ó¼¼±ÕÃÑ
  • full term normal delivery =FTND
    ¸¸±âÁ¤»óºÐ¸¸(ػѢïáßÈÝÂØ´).
  • full term normal vaginal delivery
    ¸¸±âÁ¤»ó°æÁú½ÄºÐ¸¸.
  • half normal solution
    0.5 ±ÔÁ¤¾×(¡­Ð®ïÒäû).
  • last normal menstrual period (LNMP)
    ÃÖÁ¾ Á¤»ó ¿ù°æÀÏ (õÌðû ïáßÈ êÅÌèìí)
  • last normal menstrual period =LNMP
    ÃÖÁ¾Á¤»ó¿ù°æ±â(õÌðûïáßÈêÅÌèÑ¢).
  • logarithmic normal distribution
    ·Î±×Á¤±ÔºÐÆ÷, ´ë¼öÁ¤±ÔºÐÆ÷(ÊÙËøË»ËÓ̰).
  • normal
    1.Á¤»óÀÇ 2.³óµµÀÇ ´ÜÀ§,1±×·¥´ç·®/1000ml
  • normal bacterial flora
    Á¤»ó¼¼±ÕÃÑ.
  • normal curve
    Á¤±Ô°î¼±(ËøË»Ë­ËÛ).
  • normal diet
    º¸Åë½Ä(ÜÅ÷×ãÝ).
  • normal dispersion
    Á¤»óºÐ»ê(~ËÓË×).
  • normal distribution
    Á¤±ÔºÐÆ÷(ËøË»ËÓ̰).
  • normal dwarf
    Á¤»ó¼ÒÀÎÁõ, ³­ÀåÀÌ »ý¸®Àû ÁÖ À¯(ßæìµîÜñ­êã) .
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IC icteric, icterus; immune complex; immunoconjugate; immunocytochemistry; immunocytotoxicity; impedanc...
ID identification; iditol dehydrogenase; immunodeficiency; immunodiffusion; immunoglobulin deficiency; ...
IHCA individual health care account; isocapnic hyperventilation with cold air
IMP idiopathic myeloid proliferation; impression; incomplete male pseudohermaphroditism; individual Medi...
IMR individual medical record; infant mortality rate; infant mortality risk; Institute for Medical Resea...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BCO Bilateral carotid artery occlusion
BCO Bilateral carotid occlusion
BRVO Branch retinal vein occlusion
CRAO Central retinal artery occlusion
CRVO Central retinal vein occlusion
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • normal eruption process
    Á¤»ó ¸ÍÃâ °úÁ¤
  • normal flora
    Á¤»ó ±ÕÃÑ, Á¤»ó ±ÕÃѱº
  • normal immunoglobulin
    Á¤»ó ¸é¿ª
  • normal potential
    Á¤»ó ÀüÀ§
  • normal pressure hydrocephalus
    Á¤»ó¾Ð ¼öµÎÁõ
  • normal saline solution
    Á¤¼º »ý¸® ½Ä¿°¼ö
  • normal sinus rhythm
    Á¤»ó µ¿¹æ °áÀý ¸®µë
  • normal value
    Á¤»óÄ¡, Ç¥ÁØÄ¡, ±ÔÁ¤Ä¡
  • within normal limit
    Á¤»ó ¹üÀ§³»
  • acentric occlusion
    ºñÁ᫐ ±³ÇÕ
    Áß½ÉÀ§ °ü°è·Î Æó±¸ÇÒ ¶§ Á¶±â Á¢ÃËÀ» ÀÏÀ¸ÄÑ Áß½ÉÀ§ °ü°è¿Í ÀÏÄ¡ÇÏÁö ¾Ê´Â ÇϾǰñÀÇ ½À°ü¼º Æó±¸ »óÅÂ.
  • Angle's classification of occlusion
    ±³ÇÕÀÇ Angle ºÐ·ù, ¾Þ±Û¾¾ ºÐ·ù
    1. »óÇÏ¾Ç ±¸Ä¡¿Í ÀýÄ¡ °ü°è¿¡ ±Ù°ÅÇÑ ±³ÇÕÀÇ ºÐ·ù. 2. óÀ½¿¡ ¾Þ±Û¿¡ ÀÇÇØ ±â¼úµÈ ÀüÈÄ¹æ ¾Ç°£ °ü°è¿¡ ´ëÇØ 4°¡Áö ÁÖ¿ä ±¸ºÐÀ¸·Î ¼³¸íµÇ¾ú´ø Á¦ 1´ë±¸Ä¡ÀÇ ±³ÇÕ ¾ç»ó¿¡ ±âÃʸ¦ µÐ ±³Çպзù¹ý.
  • anterior choroidal artery occlusion syndrome
    Àü¸Æ¶ô Ãѵ¿¸Æ Æó¼â ÁõÈıº
  • arterial occlusion
    µ¿¸Æ ÇùÂø
  • balanced occlusion
    ±ÕÇü ±³ÇÕ
    ÅÎÀÇ ÀÛ¾÷ÃøÀÇ Ä¡¾Æ¿Í ¹Ý´ëÃø Ä¡¾ÆÀÇ ±³ÇÕÁ¢ÃËÀÌ Á¶È­µÈ °Í. ÀÇÄ¡ÀÇ ±³ÇÕÀº ±³ÇÕ±â»ó¿¡¼­ ÇàÇÏ¿©Áö¹Ç·Î ±â°èÀûÀ¸·Î´Â ÆòÇüÀÌ ÀÌ·ç¾îÁö°ÚÁö¸¸, »ý¸®ÇÐÀû °í·Á ¶Ç´Â »ý¸®ÇÐÀû ÆòÇü¿¡ À־ ÃøµÎÇϾǰüÀýÀÇ ±â´É ¹× ½Å°æ±ÙÀ°°è¿ÍÀÇ Á¶È­µÈ ±â´ÉÀº ¾ø´Ù.
  • bilateral balanced occlusion
    ¾çÃø¼º ±ÕÇü ±³ÇÕ
    ÇϾÇÀÌ Áß½ÉÀ§¿Í Æí½ÉÀ§¿¡ À§Ä¡ÇÒ ¶§, Ä¡¾ÆµéÀÌ Àü¹æºÎ¿Í ÈĹæºÎ ¸ðµÎ¿¡¼­ ¾çÃø¼ºÀ¸·Î µ¿½Ã¿¡ Á¢ÃËÇÏ´Â ±³ÇÕ ¾ç½Ä.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
normal bite That arrangement of teeth and their supporting structure which is usually found in health and which approaches an ideal or standard arrangement.
Synonym: normal bite.
Synonym: neutral occlusion.
(05 Mar 2000)
normal butyric acid (also written as n-butyric acid), butanoic acid, CH3CH2CH2COOH, which occurs in combination with glycerol in cow's butter; and isobutyric acid, 2-methylpropanoic acid, (CH3)2CHCOOH, one of the intermediates in valine catabolism, found in combination with glycerol in croton oil and elsewhere.
(05 Mar 2000)
normal cholesteraemic xanthomatosis histiocytosis
normal distribution Continuous frequency distribution of infinite range. Its properties are as follows: 1) continuous, symmetrical distribution with both tails extending to infinity; 2) arithmetic mean, mode, and median identical; and 3) shape completely determined by the mean and standard deviation.
(12 Dec 1998)
normal electrical axis A mean electrical axis of the heart situated between -30
normal hearing The ability to perceive sound normally.
Synonym: normal hearing.
Origin: G. Akousis, hearing
(05 Mar 2000)
normal horse serum The sterile and filtered serum of a healthy, unvaccinated horse.
(05 Mar 2000)
normal human plasma Sterile plasma obtained by pooling approximately equal amounts of the liquid portion of citrated whole blood from eight or more adult humans who have been certified as free from any disease which is tranmissible by transfusion, and treating it with ultraviolet irradiation to destroy possible bacterial and viral contaminants.
(05 Mar 2000)
normal human serum Sterile serum obtained by pooling approximately equal amounts of the liquid portion of coagulated whole blood from eight or more persons who are free from any disease transmissible by transfusion.
(05 Mar 2000)
normal human serum albumin A sterile preparation of serum albumin obtained by fractionating blood plasma proteins from healthy persons; used as a transfusion material and to treat oedema due to hypoproteinaemia.
Synonym: dried human albumin.
(05 Mar 2000)
normal opsonin That normally present in the blood, i.e., without stimulation by a known, specific antigen such as certain complement components; it is relatively thermolabile and reacts with various organisms.
Synonym: common opsonin, thermolabile opsonin.
Specific opsonin, antibodies formed in response to stimulation by a specific antigen, either as a result of an attack of a disease, or injections with a suitably prepared suspension of the specific microorganism.
Synonym: immune opsonin, thermostable opsonin.
(05 Mar 2000)
normal pressure hydrocephalus <neurology> A brain disorder caused by blockage of the flow of cerebrospinal fluid (CSF), with enlargement of the ventricles of the brain (keep the pressure normal) and compression of brain tissue. Brain atrophy is the result. In this condition the CSF is produced normally but not reabsorbed.
Symptom onset is gradual. A key feature is dementia. Treatment is surgical (VP shunt).
(13 Nov 1997)
normal range Normal results can fall outside the normal range. By convention, the normal range is set to cover ninety-five percent (95%) of values from a normal population. Five percent (5%) of normal results therefore fall outside the normal range.
(12 Dec 1998)
normal serum A nonimmune serum, usually with reference to a serum obtained prior to immunization.
(05 Mar 2000)
normal tartrate Tartrate that contains no uncombined acid groups.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á